NCT00600366: Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes |
|
|
| Completed | 4 | 71 | RoW | biphasic insulin aspart, BIASP, NovoMix 30, NovoLog 70/30 Mix | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 01/05 | 01/05 | | |
